Mealey's (March 7, 2024, 2:01 PM EST) -- NEW ORLEANS — The Fifth Circuit U.S. Court of Appeals held oral arguments on March 6 in an interlocutory appeal of the Taxotere XE "Taxotere" hair loss multidistrict litigation court’s ruling that three generic drug manufacturers are not protected by preemption because newly acquired risk information could have been added to the drug label....